Universität zu Köln

Doering, Mandy, Ba, Lalla A., Lilienthal, Nils, Nicco, Carole ORCID: 0000-0001-8211-2556, Scherer, Christiane, Abbas, Muhammad, Zada, Abdul Ali Peer, Coriat, Romain, Burkholz, Torsten ORCID: 0000-0002-5497-368X, Wessjohann, Ludger, Diederich, Marc ORCID: 0000-0003-0115-4725, Batteux, Frederic ORCID: 0000-0002-1265-7996, Herling, Marco and Jacob, Claus (2010). Synthesis and Selective Anticancer Activity of Organochalcogen Based Redox Catalysts. J. Med. Chem., 53 (19). S. 6954 - 6964. WASHINGTON: AMER CHEMICAL SOC. ISSN 1520-4804

Lilienthal, Nils (2011). Targeting apoptotic resistance in chronic lymphocytic leukemia (CLL). Thesis Abstract, Universität zu Köln.

Lilienthal, Nils, Lohmann, Gregor, Crispatzu, Giuliano, Vasyutina, Elena ORCID: 0000-0001-9722-3419, Zittrich, Stefan, Mayer, Petra, Herling, Carmen Diana, Tur, Mehmet Kemal ORCID: 0000-0002-9259-6723, Hallek, Michael, Pfitzer, Gabriele, Barth, Stefan ORCID: 0000-0001-9589-653X and Herling, Marco (2016). A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells. Mol. Cancer Ther., 15 (5). S. 971 - 985. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-8514

Schrader, Alexandra, Popal, Wagma, Lilienthal, Nils, Crispatzu, Giuliano, Mayer, Petra, Jones, Dan, Hallek, Michael and Herling, Marco (2014). AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1. Curr. Cancer Drug Targets, 14 (8). S. 700 - 713. SHARJAH: BENTHAM SCIENCE PUBL LTD. ISSN 1873-5576